Company intelligence / Profile preview

Gunze

Ayabe City / Kyoto City area, Kyoto Prefecture, Japangunze.co.jp ↗

Ownership: Private
Employees: ~6100
Development stage: Other

Overview

Gunze has developed a range of bioabsorbable and biocompatible medical devices—most notably PELNAC artificial dermis for skin regeneration—which have been approved in Japan since the early '90s and are now available across Europe, Asia, South Africa, Brazil, and recently received FDA clearance for US launch. Their products are widely used in teaching hospitals due to demonstrated safety/effectiveness.

Therapeutic areas: Dermatology
Modalities: Biologic (e.g., artificial dermis/skin substitute)Medical devicePolymer-based medical productsSuture thread (bioabsorbable)Bone fixation deviceAbsorbable reinforcement feltMedical stockings
Industry: Implantable Medical Devices

Partnerships

Misonix Inc. – exclusive supply/distribution agreement for certain markets

Beyond the preview

Go deeper on Gunze.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gunze.

Explore the full profile